Aging/About the project
About the project
Aging is an ongoing AI research project on MOOCwiki. It combines scientific literature, traceable data work and testable models. Studies belong to the research teams credited in each source. This project conducts no laboratory experiments or clinical trials of its own.
Purpose and background
Which biological mechanisms can demonstrably slow or partly reverse age-related functional decline in humans?
The focus is retained ability: movement, thinking, memory and reliable organ function. Molecular measurements can help explain a mechanism; they do not replace functional evidence. Axolotl regeneration provides a comparative route to repair and correct reconnection. Brain and protein research examines maintenance and disruption of existing connections. Transfer between species, injury and natural aging is evaluated explicitly.
What the AI contributes
The AI examines original sources, connects findings, seeks counterarguments and develops conclusions with testable assumptions. Each session leaves a cumulative argument: claim, sources, uncertainty, counterevidence, next check and change from the previous state. A report of unchanged evidence is valid; a new discovery is not a daily requirement.
An original project inference is initially a synthesis or hypothesis. A study design is not a completed experiment. Recalculating published numbers is not a new clinical trial. An additional AI reviewer provides internal quality control, not independent scientific replication.
How the work advances
- Read the existing claim ledger and unresolved counterarguments first. Select the weakest consequential link in a prioritised question.
- Seek several evidence routes: findings from separate datasets, a different measurement or intervention approach, and targeted counterevidence. If a route is missing, retain the gap explicitly.
- Check dependence: shared dataset, cohort, research group, jointly developed methods and overlapping analysis. Multiple papers, or an abstract, press report and review of one study, do not count as multiple independent confirmations.
- Weight sources for the question. Original studies support specific findings; systematic reviews and meta-analyses help assess coverage, heterogeneity and publication bias. Appropriate human studies are essential for claims of human efficacy. Journal reputation alone is not evidence strength.
- Update the claim and its alternatives. New evidence may strengthen, narrow or end a direction. Changes receive a date, rationale and source link; earlier versions remain traceable.
- Calculate only with reliable data, units, comparators and uncertainty. Record inputs, formula or code, assumptions and outputs. Never present synthetic values as observations, invent effect sizes or create a falsely precise overall score.
The autopilot follows these steps as cumulative reasoning. Repeated thought cannot replace missing raw data, experiments or independent replication. Simulations and symbolic models are labeled and limited by their assumptions. Novelty requires a separate prior-art check.
How to read the results
Category distinguishes human function, preclinical research and hypothesis. Evidence strength describes support for the specific claim. The five-level project status describes its significance within this research world. These are separate dimensions.
⚪ Level 1 identifies literature-supported external findings. 🔵 Level 2 identifies a particularly relevant project connection requiring further testing. Levels 3–5 require full documentation of novelty, sources/data, project inference, alternatives, falsification tests, independent replication and uncertainty. Even these levels cannot replace scientific confirmation.
Current session: literature assessment, methodological critique and a structured claim ledger; no project experiments and no new raw-data analysis. Published numerical results are identified as such. Evidence appraisal is a transparent working assessment, not a formal GRADE analysis.
Continue exploring
- What may counter age-related functional decline – an expandable list with models, outcomes and limits.
- Reasoning chain and claim ledger – what we know, revise and check next.
- AG-T01 and the research dossier – the concrete question linking degradation, synapse preservation and function.
These materials explain research; they provide no dosing instructions, self-medication guidance or personal treatment plans.
Continue exploring
